It’s a 3 Horse Race to Win Skin Cancer Drug Sales
At the moment only ‘Zelboraf’ or ‘Vemurafenib’ out of the Roche Big Pharma stables are approved for treating melanoma cancers.
Read more
pharmaceutical company
Merck & Co at a Crossroads with the Next Warfarin Heart Drug
Vorapaxar, Merck & Co’s latest heart medication is not good enough for patients and may be very bad for Merck.
Read more